Upcoming and Current Events

Poster presentations:

Session: Biomarkers of GI Cancers (P8225)
Details: Sunday, May 20, 2012, 8:00 a.m. - 5:00 p.m. PT
Location: San Diego Convention Center, Halls C-G

Title: Plasma Methylated Sept9 Is a Screening Marker in Both Left- and Right-Sided Colon Cancer. Comparison to FOBT and CEA Results
Lead Author: Professor Dr. Kinga Toth from the 2nd Department of Internal Medicine of Semmelweis University in Budapest, Hungary
Abstract No. Su1895

Title: Sept9 DNA Methylation in Healthy, Adenoma and Colorectal Cancer Patients: a Comparison Between Tissue and Plasma Specimens
Lead Author: Professor Dr. Kinga Toth from the 2nd Department of Internal Medicine of Semmelweis University in Budapest, Hungary
Abstract No. Su1892

Booth No. 15

Reporting period: January 1 – June 30, 2012

Reporting period: January 1 – September 30, 2012